Last reviewed · How we verify
CE Ferulic
CE Ferulic is a Small molecule drug developed by Goldman, Butterwick, Fitzpatrick and Groff. It is currently in Phase 2 development for Photoaging and fine lines (cosmetic/anti-aging indication), Skin antioxidant protection.
CE Ferulic is a topical antioxidant serum combining vitamin C, vitamin E, and ferulic acid to neutralize free radicals and protect skin from oxidative damage.
CE Ferulic is a topical antioxidant serum combining vitamin C, vitamin E, and ferulic acid to neutralize free radicals and protect skin from oxidative damage. Used for Photoaging and fine lines (cosmetic/anti-aging indication), Skin antioxidant protection.
-
Baseline phase 2 → approval rate
+15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2031–2034 | — |
| EMA | EU | 2032–2035 | +0.7 yr |
| MHRA | GB | 2032–2035 | +0.7 yr |
| Health Canada | CA | 2032–2036 | +0.9 yr |
| TGA | AU | 2032–2036 | +1.2 yr |
| PMDA | JP | 2032–2036 | +1.5 yr |
| NMPA | CN | 2033–2037 | +2.3 yr |
| MFDS | KR | 2032–2036 | +1.4 yr |
| CDSCO | IN | 2032–2037 | +1.8 yr |
| ANVISA | BR | 2033–2037 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | CE Ferulic |
|---|---|
| Sponsor | Goldman, Butterwick, Fitzpatrick and Groff |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 2 |
Mechanism of action
The formulation works synergistically: L-ascorbic acid (vitamin C) provides antioxidant protection and collagen synthesis support, vitamin E enhances stability and provides additional antioxidant benefits, and ferulic acid stabilizes the vitamins and amplifies their photoprotective effects. This combination is designed to improve skin texture, reduce signs of aging, and provide photoprotection when used with sunscreen.
Approved indications
- Photoaging and fine lines (cosmetic/anti-aging indication)
- Skin antioxidant protection
Common side effects
- Mild irritation or redness
- Sensitivity in patients with vitamin C intolerance
Key clinical trials
- Enhanced Photoaging Reversal Efficacy and Safety of 755nm Alexandrite Picosecond Laser with Diffractive Lens Array (DLA) in Conjunction with Integrated Skin Care for Skin Quality Improvement (NA)
- Skin Care Regimen for Improving Photoaging Signs on the Face (PHASE2, PHASE3)
- A Clinical Study to Evaluate the Efficacy and Safety of Monopolar Radiofrequency Combined With SkinCeuticals A.G.E and Skinceuticals CE FERULIC for Improving Facial Skin Elasticity, Tightening and Fading Fine Lines (NA)
- A Clinical Study to Evaluate the Efficacy and Satisfaction of the Skinceuticals Skin Care Product (CE FERULIC) for Skin Repair Post Fraxel Laser Treatment (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CE Ferulic CI brief — competitive landscape report
- CE Ferulic updates RSS · CI watch RSS
- Goldman, Butterwick, Fitzpatrick and Groff portfolio CI
Frequently asked questions about CE Ferulic
What is CE Ferulic?
How does CE Ferulic work?
What is CE Ferulic used for?
Who makes CE Ferulic?
What development phase is CE Ferulic in?
What are the side effects of CE Ferulic?
Related
- Manufacturer: Goldman, Butterwick, Fitzpatrick and Groff — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Photoaging and fine lines (cosmetic/anti-aging indication)
- Indication: Drugs for Skin antioxidant protection
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing